Voluntary announcement - latest update on the cooperation with rejuven
Filed with HKEX · Stock code 2487 · · 2 pages · English
Summary by 6ix AI
The announcement details a supplemental agreement that expands the geographical scope of their collaboration beyond Asia. Both companies will now seek third-party partners for out-licensing opportunities and enhance their cooperation on clinical development and commercialization efforts.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Cutia Therapeutics
- Next Day Disclosure Return
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement - share repurchase program under the share repurchase mandate
- List of directors and their roles and functions
- Change of executive director
Later from Cutia Therapeutics
All Cutia Therapeutics news releasesFollow Cutia Therapeutics into a list and get an email when it puts out news.
Follow Cutia Therapeutics